M&T Bank’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,003
Closed -$412K 1564
2022
Q1
$412K Sell
10,003
-5,204
-34% -$214K ﹤0.01% 1071
2021
Q4
$661K Buy
15,207
+443
+3% +$19.3K ﹤0.01% 905
2021
Q3
$739K Sell
14,764
-280
-2% -$14K ﹤0.01% 848
2021
Q2
$948K Sell
15,044
-3,723
-20% -$235K ﹤0.01% 776
2021
Q1
$1.74M Buy
18,767
+35
+0.2% +$3.25K 0.01% 593
2020
Q4
$1.68M Buy
18,732
+3,220
+21% +$289K 0.01% 616
2020
Q3
$1.6M Sell
15,512
-3,670
-19% -$379K 0.01% 582
2020
Q2
$1.52M Sell
19,182
-4,739
-20% -$375K 0.01% 582
2020
Q1
$1.38M Buy
23,921
+208
+0.9% +$12K 0.01% 606
2019
Q4
$1.28M Sell
23,713
-2,481
-9% -$134K 0.01% 543
2019
Q3
$1.37M Buy
26,194
+3,325
+15% +$174K 0.01% 619
2019
Q2
$1.11M Sell
22,869
-8,336
-27% -$403K 0.01% 706
2019
Q1
$1.58M Buy
31,205
+651
+2% +$32.9K 0.01% 587
2018
Q4
$1.81M Buy
30,554
+6,323
+26% +$375K 0.01% 517
2018
Q3
$1.6M Sell
24,231
-220
-0.9% -$14.5K 0.01% 606
2018
Q2
$1.23M Sell
24,451
-2,020
-8% -$102K 0.01% 696
2018
Q1
$1.39M Buy
26,471
+3,379
+15% +$178K 0.01% 656
2017
Q4
$1.07M Buy
23,092
+4,350
+23% +$202K 0.01% 744
2017
Q3
$758K Hold
18,742
﹤0.01% 833
2017
Q2
$635K Buy
18,742
+271
+1% +$9.18K ﹤0.01% 898
2017
Q1
$536K Buy
18,471
+1,566
+9% +$45.4K ﹤0.01% 969
2016
Q4
$555K Buy
16,905
+2,903
+21% +$95.3K ﹤0.01% 1014
2016
Q3
$441K Buy
14,002
+1,987
+17% +$62.6K ﹤0.01% 1104
2016
Q2
$338K Buy
12,015
+3,611
+43% +$102K ﹤0.01% 1186
2016
Q1
$305K Sell
8,404
-8,781
-51% -$319K ﹤0.01% 1262
2015
Q4
$688K Sell
17,185
-1,804
-10% -$72.2K ﹤0.01% 947
2015
Q3
$541K Sell
18,989
-1,681
-8% -$47.9K ﹤0.01% 1030
2015
Q2
$681K Buy
+20,670
New +$681K ﹤0.01% 1049